TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Transgenomic Inc (NASDAQ:TBIO) Investor Investigation Announced

  • If you purchased shares of Transgenomic Inc (NASDAQ:TBIO) and currently hold any of those NASDAQ:TBIO shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Transgenomic Inc
Security
NASDAQ: TBIO

Summary

June 7, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Transgenomic Inc (NASDAQ:TBIO) was announced over potential breaches of fiduciary duties by certain officers and directors at Transgenomic.

The investigation by a law firm concerns whether certain Transgenomic officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Transgenomic Inc reported that its annual Total Revenue declined from $27.54 million in 2013 to $1.24 million in 2014, respectively $1.65 million in 2015.

Shares of Transgenomic Inc (NASDAQ:TBIO) declined from $4.00 per share in early 2014 to as low as $0.48 per share on May 13, 2016.

On June 7, 2016, NASDAQ:TBIO shares closed at $0.67 per share.

Start Monitoring Your Investments